News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,436 Results
Type
Article (39426)
Company Profile (249)
Press Release (653761)
Section
Business (204054)
Career Advice (2006)
Deals (35409)
Drug Delivery (93)
Drug Development (80971)
Employer Resources (169)
FDA (16138)
Job Trends (14832)
News (344939)
Policy (32483)
Tag
Academia (2537)
Alliances (49330)
Alzheimer's disease (1317)
Approvals (16124)
Artificial intelligence (208)
Bankruptcy (357)
Best Places to Work (11638)
Biotechnology (177)
Breast cancer (230)
Cancer (1767)
Cardiovascular disease (132)
Career advice (1670)
CAR-T (128)
Cell therapy (368)
Clinical research (65351)
Collaboration (688)
Compensation (379)
COVID-19 (2569)
C-suite (171)
Data (1686)
Diabetes (221)
Diagnostics (6298)
Earnings (85652)
Employer resources (145)
Events (111091)
Executive appointments (583)
FDA (17076)
Funding (617)
Gene therapy (252)
GLP-1 (657)
Government (4362)
Healthcare (18783)
Infectious disease (2686)
Interviews (311)
IPO (16466)
Job creations (3627)
Job search strategy (1421)
Layoffs (440)
Legal (7893)
Lung cancer (258)
Manufacturing (241)
Medical device (13275)
Medtech (13280)
Mergers & acquisitions (19333)
Metabolic disorders (572)
Neuroscience (1734)
NextGen: Class of 2025 (6509)
Non-profit (4476)
Northern California (2173)
Obesity (314)
Opinion (196)
Patents (174)
People (56889)
Phase I (20348)
Phase II (28785)
Phase III (21437)
Pipeline (780)
Postmarket research (2564)
Preclinical (8586)
Radiopharmaceuticals (242)
Rare diseases (330)
Real estate (5898)
Regulatory (21973)
Research institute (2314)
Resumes & cover letters (349)
Southern California (1863)
Startups (3569)
United States (19108)
Vaccines (620)
Weight loss (214)
Date
Today (79)
Last 7 days (758)
Last 30 days (2656)
Last 365 days (34308)
2025 (5304)
2024 (35219)
2023 (40076)
2022 (51175)
2021 (55711)
2020 (54085)
2019 (46538)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37556)
2014 (31325)
2013 (26353)
2012 (28572)
2011 (29264)
2010 (27329)
Location
Africa (717)
Arizona (211)
Asia (37545)
Australia (6138)
California (4951)
Canada (1746)
China (410)
Colorado (226)
Connecticut (234)
Europe (80513)
Florida (730)
Georgia (171)
Illinois (463)
Indiana (270)
Japan (126)
Maryland (757)
Massachusetts (3764)
Michigan (200)
Minnesota (344)
New Jersey (1401)
New York (1416)
North Carolina (853)
Northern California (2173)
Ohio (174)
Pennsylvania (1128)
South America (1093)
Southern California (1863)
Texas (725)
Utah (153)
Washington State (474)
693,436 Results for "velos inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Velo3D Announces the Commencement of OTCQX Trading
September 11, 2024
·
3 min read
Drug Development
HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease
HanAll Biopharma Co., Ltd. (KRX: 009420. KS) announced the initiation of a Phase III VELOS-4 trial evaluating the efficacy and safety of tanfanercept, a novel, topical anti-inflammatory treatment in participants with moderate to severe dry eye disease (DED).
May 3, 2024
·
7 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Drug Development
HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease
HanAll Biopharma Co., Ltd. announced results from the Phase III VELOS-3 trial evaluating the safety and efficacy of tanfanercept, a novel, topical anti-inflammatory treatment being studied for the treatment of dry eye disease (DED) in subjects diagnosed with moderate to severe DED.
May 19, 2023
·
7 min read
Press Releases
Moss Genomics Inc. Announces Leadership Changes
February 26, 2025
·
5 min read
Press Releases
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 12, 2025
·
6 min read
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
Press Releases
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
February 26, 2025
·
4 min read
Press Releases
Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval
February 24, 2025
·
4 min read
1 of 69,344
Next
